BCAX - CIK 0002023658
Bicara Therapeutics Inc. (BCAX) reported net income of -$137.95M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$137.95M | -102.9% |
| FY 2024 | -$68.00M | -30.8% |
| FY 2023 | -$51.98M | - |
Bicara Therapeutics Inc. (BCAX) reported net income of -$137.95M for fiscal year 2025, as filed in its audited annual report with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.